Legal & General Group’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6K Buy
13,802
+2,362
+21% +$2.67K ﹤0.01% 3109
2025
Q1
$16.7K Sell
11,440
-100,795
-90% -$147K ﹤0.01% 3009
2024
Q4
$239K Hold
112,235
﹤0.01% 2645
2024
Q3
$314K Buy
112,235
+1,563
+1% +$4.38K ﹤0.01% 2603
2024
Q2
$258K Buy
110,672
+15,810
+17% +$36.8K ﹤0.01% 2632
2024
Q1
$424K Buy
94,862
+12,706
+15% +$56.8K ﹤0.01% 2491
2023
Q4
$264K Buy
82,156
+847
+1% +$2.72K ﹤0.01% 2656
2023
Q3
$258K Buy
81,309
+4,103
+5% +$13K ﹤0.01% 2663
2023
Q2
$384K Hold
77,206
﹤0.01% 2543
2023
Q1
$381K Buy
77,206
+2,682
+4% +$13.2K ﹤0.01% 2390
2022
Q4
$469K Buy
74,524
+1,382
+2% +$8.69K ﹤0.01% 2354
2022
Q3
$790K Sell
73,142
-2,230
-3% -$24.1K ﹤0.01% 2219
2022
Q2
$859K Buy
75,372
+13,231
+21% +$151K ﹤0.01% 2213
2022
Q1
$566K Buy
62,141
+112
+0.2% +$1.02K ﹤0.01% 2361
2021
Q4
$926K Hold
62,029
﹤0.01% 2254
2021
Q3
$1.59M Buy
62,029
+25,261
+69% +$649K ﹤0.01% 2119
2021
Q2
$959K Sell
36,768
-498
-1% -$13K ﹤0.01% 2219
2021
Q1
$1.32M Buy
37,266
+10,039
+37% +$355K ﹤0.01% 2123
2020
Q4
$687K Sell
27,227
-52
-0.2% -$1.31K ﹤0.01% 2194
2020
Q3
$1.03M Sell
27,279
-1,483
-5% -$55.9K ﹤0.01% 2016
2020
Q2
$1.23M Buy
28,762
+3,289
+13% +$141K ﹤0.01% 1914
2020
Q1
$496K Sell
25,473
-1,703
-6% -$33.2K ﹤0.01% 2067
2019
Q4
$706K Buy
27,176
+7,729
+40% +$201K ﹤0.01% 2152
2019
Q3
$530K Hold
19,447
﹤0.01% 2158
2019
Q2
$522K Sell
19,447
-82,583
-81% -$2.22M ﹤0.01% 2135
2019
Q1
$2.95M Buy
102,030
+98,721
+2,983% +$2.85M ﹤0.01% 1500
2018
Q4
$89K Buy
+3,309
New +$89K ﹤0.01% 2489